RxDoctor Payments Data

William Shappley, MD

Urology · Germantown, TNNPI 1588733992

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,298 of the $16,877 with a category attached, or 72.9%. 48 manufacturers reported payments, led by Teleflex LLC at 25.7% of the total. 2025 is the largest year on record at $4,017, 3.9 times the $1,038 reported in 2019.

$16,877in general payments, 2019–2025

Across 345 payments — averaging $48.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$4K
  • Medtronic$4K
  • Boston Scientific$1K
  • Coloplast$1K
  • Accord Healthcare, Inc.$778
  • Axonics, Inc.$748
  • plus $5K from 42 others

What the payments were for

  • Consulting fees$6504%
  • Travel & lodging$3,62021%
  • Food & beverage$12,29873%
  • Education$3092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,877 in reported general payments places this provider in the 80th percentile of 276 urology providers in Tennessee.

See all urology providers in Tennessee

Medicare billing

Part B allowed, 2024
$754,447
Medicare patients
1,049
Services billed
67,255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron79$54,584
MyrbetriqMirabegron80$51,698
Oxybutynin Chloride ErOxybutynin Chloride752$15,861
Tamsulosin Hcl934$12,498
Testosterone17$7,861
NitrofurantoinNitrofurantoin Macrocrystal119$3,439
Solifenacin Succinate33$3,232
Ciprofloxacin Hcl535$3,180
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen240$2,680
Potassium Citrate ErPotassium Citrate30$2,594
Estradiol23$1,390
Finasteride99$1,336
Dutasteride65$1,305
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav145$1,058
Alfuzosin Hcl ErAlfuzosin Hcl34$699

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$634$54,58479 claims
Astellas Pharma US IncMyrbetriq$380$51,69880 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 276 urology providers in Tennessee.

Other urology in Germantown

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →